PT  - JOURNAL ARTICLE
AU  - Mahmud, Aidalina
AU  - Lim, Poh Ying
TI  - Applying the SEIR Model in Forecasting The COVID-19 Trend in Malaysia: A Preliminary Study
AID  - 10.1101/2020.04.14.20065607
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.14.20065607
4099  - http://medrxiv.org/content/early/2020/04/17/2020.04.14.20065607.short
4100  - http://medrxiv.org/content/early/2020/04/17/2020.04.14.20065607.full
AB  - On March 18, 2020 the Malaysian government implemented a 14-day Movement Control Order (MCO) as part of the mitigation plan in controlling the COVID-19 epidemic in the country. The MCO aims to limit the contact rates among the population and hence prevent the surge of infected individuals. However, the trend of the epidemic before and after the MCO was not apparent. By applying the Susceptible, Exposed, Infectious and Removed (SEIR) mathematical model, we aimed to forecast the trend of COVID-19 epidemic in Malaysia using data from March 17 to 27, 2020. Based on several predetermined assumptions, the results of the analyses showed that after the implementation of the 14-day MCO from March 18 to 31, 2020, it is forecasted that the epidemic in Malaysia will peak approximately in the end of April 2020 and will subside by about the first week of July 2020. The MCO will “flatten the epidemic curve” but will prolong the duration of the epidemic. Decision to extend the duration of the MCO should depend on the consideration of socioeconomic factors as well.Author summary Dr. Aidalina Mahmud is a Public Health Specialist and a medical lecturer in the Department of Community Health, Universiti Putra Malaysia. Dr. Lim Poh Ying is a Biostatistician and is a senior lecturer in the Department of Community Health, Universiti Putra Malaysia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is made available with the manuscript.